Technology | July 15, 2013

New Partnership Aims to Develop Next-Generation Pacemakers and Stem Cell Pump

July 15, 2013 — Leonhardt Ventures and Core Manufacturing LLC announced a new partnership to manufacture and bring to market a lineup of medical technologies, including:

  • MyoStim Heart Pacer: The first heart pacemaker designed to recruit reparative stem cells to damaged or weakened heart tissue via a homing signal. The recruited stem cells are converted to working heart muscle.
  • Stem Cell Pump: The first implantable, wirelessly recharged pump designed to deliver controlled dosages of stem cells and growth factors to selected organs for recovery and repair.
  • AortaCell: First noninvasive device that focuses electrical energy wirelessly onto weakened aortic vessel walls to recruit stem cells and convert those cells into smooth muscle to repair an aortic aneurysm without surgery or intervention. This wireless electrical energy/stem cell technology will be the basis of a number of follow-on developments by this team.
  • CoroStim: The first vibrational-energy-emitting pacemaker add-on designed to prevent arterial plaque formation in high-risk patients.


Under the new agreement, Core Manufacturing will provide manufacturing services for active implantable devices on behalf of Leonhardt Ventures' portfolio of companies and developments. Core Manufacturing is a unique resource for OEMs looking for commercialization of complex medical devices, with capabilities that include rapid-turn prototyping and full turnkey device-level assembly, sterilization and testing, specializing in active implantable devices.

For more information: www.leonhardtventures.com

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Overlay Init